Strength
10 mg/g
Manufacturer
Oceanside PharmaceuticalsNDC
68682011102
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Last Updated
9/17/2025
Active Ingredients
PIMECROLIMUSApproval Type
Authorized Generic (NDA)
FDA Application
NDA021302On Market Since
11/26/2018
Pharmacological Classes
Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Related Drugs
Same classification
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
00378204501•Mylan Pharmaceuticals Inc.
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
00781210201•Sandoz Inc.
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
00904662361•Major Pharmaceuticals
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
16714009801•NorthStar Rx LLC
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
16729004101•Accord Healthcare Inc.
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
51079081720•Mylan Institutional LLC
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
55111052501•Dr. Reddy's Laboratories Inc.
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
59746079801•Jubilant Cadista Pharmaceuticals Inc.
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
64380072006•Strides Pharma Inc.
$0.1512
per EA
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)
Generic
67877027801•Ascend Laboratories, LLC
$0.1512
per EA